IP Library Granted Patent US 11,898,191
Granted Patent B2
US 11,898,191 · App. 17/126,971 · Granted Feb 13, 2024

Enzymatic electrochemical method for the quantification of analytes in biological fluid samples

Inventors: Laura González-Macia (Derio, ES); Maitane Urien Berrio (Derio, ES); Roberto González Rioja (Derio, ES); Arrate Jaureguibeitia Cayrols (Derio, ES); Israel Sánchez Moreno (Derio, ES); Carmen Hermida Díaz (Derio, ES)
Assignee: BIOLAN HEALTH, S.L.
C12Q1/005C12N9/0016
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,898,191
App. No.
17/126,971
Granted
Feb 13, 2024
Kind
B2
Abstract

An enzymatic electrochemical method for the quantification of analytes in isolated samples of biological fluids based on a dual biosensor strip electrochemical system. The sample is analyzed in parallel using first and second different biosensor test strips (blank and complete) and the results are obtained by subtracting a response obtained in the electrodes of the first biosensor test strip from a response obtained in the electrodes of the second biosensor test strip, thus eliminating the effect of interferences and isolating the signal corresponding only to the analyte determination.

Claims (20)

1. An enzymatic electrochemical method for quantification of an analyte in a biological fluid sample, the method comprising:

introducing the biological fluid sample in an electrochemical system formed by a first biosensor strip and a second biosensor strip, the first biosensor strip including a first working electrode modified with an enzyme and an electrochemical mediator, a first reference electrode and a first auxiliary electrode, the second biosensor strip including a second working electrode, a second reference electrode and a second auxiliary electrode, the second working electrode being modified with the enzyme, the electrochemical mediator and a cofactor;

applying a constant potential to the first and second working electrodes, the first and second reference electrodes and the first and second auxiliary electrodes during a set period of time;

obtaining current intensity data by measuring a current intensity produced by a re-oxidation of the cofactor on the second working electrode after the cofactor being initially reduced due to a reaction between the enzyme and the analyte on each of the first and second biosensor strips, and subtracting a response obtained in each of the first working electrode, first reference electrode and first auxiliary electrode from a response respectively obtained in each of the second working electrode, second reference electrode and second auxiliary electrode, the re-oxidation of the cofactor being facilitated by the electrochemical mediator;

translating the current intensity data by use of a calibration curve obtained from samples of a synthetic biological fluid comprising different concentrations of the analyte to be determined.

2. The method according to claim 1 , wherein the enzyme present on the first and second working electrodes is an oxidoreductase.

3. The method according to claim 2 , wherein the enzyme is a dehydrogenase enzyme.

4. The method according to claim 3 , where the dehydrogenase enzyme is selected from the group consisting of lactate dehydrogenase, glucose dehydrogenase, methanol dehydrogenase, glucose-6-phosphate dehydrogenase, malate dehydrogenase, glycerol-3-phosphate dehydrogenase, glycerol dehydrogenase, alcohol dehydrogenase, and D-xylose-1-dehydrogenase.

5. The method according to claim 1 , wherein the electrochemical mediator present on each of the first and second working electrodes is selected from the group consisting of tetramethylbenzidine (TMB), potassium ferricyanide, toluidine blue, hydroquinone, tetrathiafulvalene (TTF), and ferrocene.

6. The method according to claim 1 , wherein the cofactor present on the second working electrode is selected from the group consisting of nicotinamide adenine dinucleotide (NAD+), nicotinamide adenine dinucleotide phosphate (NADP+), flavin adenine dinucleotide (FAD), and flavin mononucleotide (FMN).

7. The method according to claim 6 , wherein the cofactor does not form part of a structure of the enzyme.

8. The method according to claim 1 , wherein the potential applied is between −0.2 V and +0.2 V vs. Ag/AgCI.

9. The method according to claim 8 , wherein the potential applied is between −0.05 V and +0.15 V vs. Ag/AgCI.

10. The method according to claim 1 , wherein the set period of time is between 20 seconds and 120 seconds.

11. The method according to claim 1 , wherein the set period of time is between 30 seconds and 90 seconds.

12. The method according to claim 1 , wherein the biological fluid sample is an isolated biological sample selected from the group consisting of urine, blood, serum, plasma, pleural fluid and saliva.

13. The method according to claim 1 , wherein the first and second biosensor strips reside on a same substrate.

14. The method according to claim 13 , wherein the first and second reference electrodes are one and the same.

15. The method according to claim 13 , wherein the first and second auxiliary electrodes are one and the same.

16. The method according to claim 14 , wherein the first and second auxiliary electrodes are one and the same.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 5, 2021
From: GONZÁLEZ-MACIA, LAURA; URIEN BERRIO, MAITANE; GONZÁLEZ RIOJA, ROBERTO; JAUREGUIBEITIA CAYROLS, ARRATE; SÁNCHEZ MORENO, ISRAEL; HERMIDA DÍAZ, CARMEN
To: BIOLAN HEALTH, S.L.
Reel/Frame 055161/0326 →
Priority Claims (1)
EP 18382459 · Jun 21, 2018 · regional
Continuity (2)
Continuation In Part PCTEP2019065994 · Jun 18, 2019
Related Publication 20210102232A1 · Apr 8, 2021